Valuation : TransMedics Group, Inc.

Market Cap 3.07B 2.64B 2.48B 2.26B 4.26B 293B 4.27B 29.39B 11.47B 148B 11.51B 11.26B 491B P/E 2026 *
63.5x
P/E 2027 * 40.2x
Enterprise Value 3.03B 2.61B 2.44B 2.23B 4.2B 289B 4.22B 29.01B 11.32B 146B 11.36B 11.11B 484B EV / Sales 2026 *
4.08x
EV / Sales 2027 * 3.34x
Free-Float
96.36%
Yield 2026 *
-
Yield 2027 * -
1 day-3.62%
1 week-6.69%
Current month+15.58%
1 month+15.91%
3 months+30.37%
6 months-39.12%
Current year-27.31%
1 week 88.37
Extreme 88.37
94.52
1 month 68
Extreme 68
95.18
Current year 60.1
Extreme 60.105
151.85
1 year 60.1
Extreme 60.105
156
3 years 36.42
Extreme 36.4201
177.37
5 years 10
Extreme 10
177.37
10 years 10
Extreme 10
177.37
Manager TitleAgeSince
Chief Executive Officer 57 01/08/1998
Director of Finance/CFO 55 02/12/2024
Chief Operating Officer 43 02/02/2023
Director TitleAgeSince
Director/Board Member 57 01/08/1998
Chairman 81 01/01/2011
Director/Board Member 78 01/02/2016
Date Insider Type Main position Quantity % Market Cap.
17/08/26 Don

Chairman

-18,000 0.0528%
10/07/26 Free

Chief Financial Officer

43,399 0.1273%
10/07/26 Free

Chief Operating Officer

29,511 0.0866%
Change 5-day change 1-year change 3-year change Capi.($)
-3.62%-6.69%-24.24%+44.78% 3.07B
-1.35%-1.13%+27.04%+14.12% 230B
+0.18%-1.27%+5.25%-17.37% 152B
+1.51%-1.64%-21.37%+23.59% 132B
+0.36%-7.01%-55.71%-12.92% 67.88B
+0.29%+0.47%+11.06%+18.65% 52B
+0.66%-1.69%-16.57%-13.62% 51.05B
-2.44%-3.25%+23.11%+28.29% 43.38B
-1.56%+0.97%+39.32%+47.34% 40.74B
-5.31%-1.74%+117.39%+36.28% 32.55B
Average -1.15%-1.92%+10.53%+16.91% 80.42B
Weighted average by Cap. -0.47%-1.52%+8.09%+9.43%

Financials

2026 *2027 *
Net sales 742M 639M 599M 547M 1.03B 70.89B 1.03B 7.11B 2.77B 35.78B 2.78B 2.72B 119B 875M 754M 707M 645M 1.22B 83.6B 1.22B 8.38B 3.27B 42.2B 3.28B 3.21B 140B
Net income 51.99M 44.8M 42M 38.34M 72.23M 4.97B 72.46M 498M 194M 2.51B 195M 191M 8.32B 89.08M 76.76M 71.97M 65.7M 124M 8.51B 124M 854M 333M 4.3B 334M 327M 14.25B
Net Debt -40.26M -34.69M -32.53M -29.69M -55.93M -3.85B -56.11M -386M -151M -1.94B -151M -148M -6.44B -146M -126M -118M -107M -202M -13.92B -203M -1.4B -545M -7.03B -547M -535M -23.3B
Logo TransMedics Group, Inc.
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Employees
898
Date Price Change Volume
28/08/26 $88.43 -3.62% 631,047
27/08/26 $91.75 -0.51% 418,390
26/08/26 $92.22 -1.47% 448,872
25/08/26 $93.60 0.00% 405,438
24/08/26 $93.60 -1.23% 770,374
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
88.43USD
Average target price
97.30USD
Spread / Average Target
+10.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMDX Stock